Xtant Medical Holdings (XTNT) Change in Account Payables (2010 - 2025)
Xtant Medical Holdings (XTNT) reported Change in Account Payables of -$399000.0 for Q3 2025, down 130.57% year-over-year from $1.3 million in Q3 2024, and down 4090.0% quarter-over-quarter from $10000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Change in Account Payables (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Change in Account Payables data on file, last reported at -$399000.0 in Q3 2025.
- Change in Account Payables for Q3 2025 came in at -$399000.0, down 130.57% year-over-year; the trailing twelve-month figure through Sep 2025 was -$1.5 million (down 151.68% YoY), and the FY2024 annual result was $1.0 million, down 65.34% from the prior year.
- Change in Account Payables fell to -$399000.0 in Q3 2025 per XTNT's latest filing, from $10000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $1.7 million in Q4 2023 and troughed at -$890000.0 in Q1 2025.
- A 5-year average of $172473.7 and a median of $151000.0 in 2021 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables jumped 813.04% in 2024, then tumbled 280.89% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $260000.0 in 2021, then sank by 211.15% to -$289000.0 in 2022, then soared by 682.01% to $1.7 million in 2023, then sank by 115.28% to -$257000.0 in 2024, then slumped by 55.25% to -$399000.0 in 2025.
- Business Quant data shows XTNT's Change in Account Payables at -$399000.0 in Q3 2025, $10000.0 in Q2 2025, and -$890000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 221.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Xtant Medical Holdings | 62.75 Mn | 45.42 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -399,000.00 |
| Sep 30, 2025 | -399,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | -890,000.00 |
| Mar 31, 2025 | -890,000.00 |
| Dec 31, 2024 | -257,000.00 |
| Dec 31, 2024 | -257,000.00 |
| Sep 30, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | -507,000.00 |
| Jun 30, 2024 | -507,000.00 |
| Mar 31, 2024 | 492,000.00 |
| Mar 31, 2024 | 492,000.00 |
| Dec 31, 2023 | 1.68 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 344,000.00 |
| Sep 30, 2023 | 344,000.00 |
| Jun 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 1.02 Mn |